Vogli Trio 0.2 Tablet SR
Marketer
Medley Pharmaceuticals
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Vogli Trio 0.2 Tablet SR
Tri-Vogli 0.2mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Administer Tri-Vogli 0.2mg ER tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, vomiting, diarrhea, abdominal discomfort, edema (swelling), blurred vision, bone fractures, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Primary Ingredients of Vogli Trio 0.2 Tablet SR
No text provided to rephrase.
Uses of Vogli Trio 0.2 Tablet SR
Managing type 2 diabetes
Major Benefits of Vogli Trio 0.2 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vogli Trio 0.2 Tablet SR whole; avoid chewing, crushing, or breaking it. It should be administered with food.
Common Side effects of Vogli Trio 0.2 Tablet SR:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Vogli Trio 0.2 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Vogli Trio 0.2 SR tablets should be administered with a meal.
How Vogli Trio 0.2 Tablet SR works:
Vogli Trio SR 0.2mg tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogli Trio 0.2 Tablet SR and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Vogli Trio 0.2mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
The extended-release Vogli Trio 0.2mg tablet requires careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Vogli Trio 0.2 SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is recommended. Vogli Trio 0.2 SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Exercise caution when prescribing Vogli Trio 0.2 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver disease, initiate Vogli Trio 0.2 Tablet SR therapy with a reduced starting dose; its administration is contraindicated in those with severe liver dysfunction.
What if you forget to take Vogli Trio 0.2 Tablet SR :
NA
Facts to Know About Vogli Trio 0.2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
3,018 People bought this recently